Semaglutide works by activating GLP-1 receptors in your brain's appetite centers, fundamentally altering how you experience hunger and food desire
Its prolonged half-life, due to molecular modifications that increase albumin binding and resist enzymatic degradation, allows for sustained therapeutic effects with once-weekly administration
A spokesperson for Novo Nordisk, the company that makes Wegovy and Ozempic (a brand of semaglutide that is used to treat diabetes), says that semaglutide did not appear to affect growth or pubertal development during the [2022] trial period
You can influence the quality of your weight loss through progressive resistance training, adequate nutrition, regular movement, hydration, recovery and medical supervision
A weight loss consultation at ILU Collective includes a comprehensive medical history review, baseline bloodwork panel, body composition assessment, and a one-on-one discussion with your provider about your goals and candidacy for GLP-1 therapy
doi: 10.1136/bmj-2025-086886